nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARB—prostate gland—urinary bladder cancer	0.0122	0.104	CbGeAlD
Isotretinoin—RXRG—prostate gland—urinary bladder cancer	0.012	0.102	CbGeAlD
Isotretinoin—RARG—prostate gland—urinary bladder cancer	0.00997	0.0851	CbGeAlD
Isotretinoin—RARA—prostate gland—urinary bladder cancer	0.00938	0.0801	CbGeAlD
Isotretinoin—RXRA—renal system—urinary bladder cancer	0.00928	0.0792	CbGeAlD
Isotretinoin—RXRA—female reproductive system—urinary bladder cancer	0.00743	0.0634	CbGeAlD
Isotretinoin—RARG—urethra—urinary bladder cancer	0.00668	0.057	CbGeAlD
Isotretinoin—RARB—female reproductive system—urinary bladder cancer	0.00667	0.057	CbGeAlD
Isotretinoin—RARA—renal system—urinary bladder cancer	0.00639	0.0546	CbGeAlD
Isotretinoin—RARB—vagina—urinary bladder cancer	0.00604	0.0515	CbGeAlD
Isotretinoin—RXRB—vagina—urinary bladder cancer	0.00555	0.0474	CbGeAlD
Isotretinoin—RARG—female reproductive system—urinary bladder cancer	0.00544	0.0465	CbGeAlD
Isotretinoin—RARA—female reproductive system—urinary bladder cancer	0.00512	0.0437	CbGeAlD
Isotretinoin—RARG—vagina—urinary bladder cancer	0.00492	0.042	CbGeAlD
Isotretinoin—RARB—lymph node—urinary bladder cancer	0.0039	0.0333	CbGeAlD
Isotretinoin—RARG—lymph node—urinary bladder cancer	0.00319	0.0272	CbGeAlD
Isotretinoin—RARA—lymph node—urinary bladder cancer	0.00299	0.0256	CbGeAlD
Isotretinoin—RXRG—Adipogenesis—RB1—urinary bladder cancer	0.000685	0.00237	CbGpPWpGaD
Isotretinoin—RXRA—Mitochondrial biogenesis—CREBBP—urinary bladder cancer	0.000681	0.00235	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IGF1—urinary bladder cancer	0.000679	0.00234	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.000675	0.00233	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—PPARG—urinary bladder cancer	0.000673	0.00232	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—CREBBP—urinary bladder cancer	0.000671	0.00232	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—urinary bladder cancer	0.00066	0.00228	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000646	0.00223	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—RB1—urinary bladder cancer	0.000644	0.00222	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IGF1—urinary bladder cancer	0.000639	0.0022	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—HPGDS—urinary bladder cancer	0.000633	0.00219	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.000627	0.00217	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000619	0.00214	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTT1—urinary bladder cancer	0.000614	0.00212	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—urinary bladder cancer	0.000587	0.00203	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000583	0.00201	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—NQO1—urinary bladder cancer	0.000582	0.00201	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000579	0.002	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000571	0.00197	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000568	0.00196	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000566	0.00195	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.00056	0.00193	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000548	0.00189	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000547	0.00189	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000545	0.00188	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000542	0.00187	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—urinary bladder cancer	0.000533	0.00184	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000528	0.00182	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000517	0.00178	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.000512	0.00177	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000496	0.00171	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CDKN1A—urinary bladder cancer	0.000492	0.0017	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.00049	0.00169	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—NCOR1—urinary bladder cancer	0.00049	0.00169	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTP1—urinary bladder cancer	0.000486	0.00168	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000475	0.00164	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000473	0.00163	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000471	0.00162	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000469	0.00162	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000466	0.00161	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000463	0.0016	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000463	0.0016	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000458	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000457	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—urinary bladder cancer	0.000457	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—EP300—urinary bladder cancer	0.000457	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CNTN2—urinary bladder cancer	0.00045	0.00155	CbGpPWpGaD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—NCOR1—urinary bladder cancer	0.000449	0.00155	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GSTM1—urinary bladder cancer	0.000446	0.00154	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000444	0.00153	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000444	0.00153	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—FAS—urinary bladder cancer	0.000439	0.00151	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTP1—urinary bladder cancer	0.000426	0.00147	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000415	0.00143	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000406	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Orphan transporters—CREBBP—urinary bladder cancer	0.000403	0.00139	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000401	0.00138	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000399	0.00138	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000398	0.00137	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000392	0.00135	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—GSTM1—urinary bladder cancer	0.000391	0.00135	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000389	0.00134	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000385	0.00133	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000382	0.00132	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—urinary bladder cancer	0.00038	0.00131	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000377	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000377	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000371	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—urinary bladder cancer	0.000367	0.00127	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000367	0.00127	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000365	0.00126	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000364	0.00126	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000358	0.00124	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—urinary bladder cancer	0.000358	0.00123	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000355	0.00123	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000354	0.00122	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000352	0.00121	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—PPARG—urinary bladder cancer	0.000351	0.00121	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.000349	0.0012	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000343	0.00118	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000343	0.00118	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.00034	0.00117	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000339	0.00117	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000338	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—RB1—urinary bladder cancer	0.000336	0.00116	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IGF1—urinary bladder cancer	0.000333	0.00115	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000328	0.00113	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000324	0.00112	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000323	0.00111	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000315	0.00109	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000313	0.00108	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000311	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—CREBBP—urinary bladder cancer	0.000309	0.00107	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000294	0.00102	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000288	0.000994	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000287	0.000989	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000286	0.000987	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SMC1A—urinary bladder cancer	0.000285	0.000985	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000285	0.000984	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000284	0.00098	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.000283	0.000978	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000283	0.000976	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000282	0.000974	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000281	0.00097	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000276	0.000953	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000275	0.000948	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000274	0.000946	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000272	0.000939	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.00027	0.000934	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000269	0.00093	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000269	0.00093	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000263	0.000907	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—EP300—urinary bladder cancer	0.000262	0.000906	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000261	0.000903	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SMC1A—urinary bladder cancer	0.000261	0.000901	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTZ1—urinary bladder cancer	0.000261	0.000901	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000261	0.0009	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.00026	0.000897	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000257	0.000886	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000256	0.000885	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SMC1A—urinary bladder cancer	0.000256	0.000884	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000251	0.000867	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ESR2—urinary bladder cancer	0.000249	0.000859	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000248	0.000855	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTO2—urinary bladder cancer	0.000247	0.000854	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NAT1—urinary bladder cancer	0.000247	0.000854	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000246	0.00085	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000246	0.000849	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000246	0.000849	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMC1A—urinary bladder cancer	0.000245	0.000847	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMC1A—urinary bladder cancer	0.000245	0.000847	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000245	0.000845	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000243	0.00084	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000242	0.000834	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000241	0.000833	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000236	0.000815	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000236	0.000815	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000232	0.0008	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000232	0.000799	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ESR2—urinary bladder cancer	0.000227	0.000785	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—UGT2B7—urinary bladder cancer	0.000226	0.000781	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR2—urinary bladder cancer	0.000223	0.00077	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR2—urinary bladder cancer	0.000214	0.000738	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR2—urinary bladder cancer	0.000214	0.000738	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00021	0.000726	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000207	0.000716	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP4B1—urinary bladder cancer	0.000204	0.000703	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000203	0.0007	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC19A1—urinary bladder cancer	0.000192	0.000664	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NCOR1—urinary bladder cancer	0.000192	0.000663	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PRSS3—urinary bladder cancer	0.000187	0.000647	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—TNF—urinary bladder cancer	0.000186	0.000643	CbGpPWpGaD
Isotretinoin—Abdominal pain—Etoposide—urinary bladder cancer	0.000183	0.000309	CcSEcCtD
Isotretinoin—Body temperature increased—Etoposide—urinary bladder cancer	0.000183	0.000309	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000183	0.000309	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000183	0.000309	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000183	0.000633	CbGpPWpGaD
Isotretinoin—Hepatitis—Epirubicin—urinary bladder cancer	0.000183	0.000308	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000183	0.000308	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—urinary bladder cancer	0.000183	0.000308	CcSEcCtD
Isotretinoin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000183	0.000308	CcSEcCtD
Isotretinoin—Tinnitus—Methotrexate—urinary bladder cancer	0.000182	0.000307	CcSEcCtD
Isotretinoin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000182	0.000307	CcSEcCtD
Isotretinoin—Asthenia—Cisplatin—urinary bladder cancer	0.000182	0.000306	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000182	0.000306	CcSEcCtD
Isotretinoin—Sweating—Doxorubicin—urinary bladder cancer	0.000181	0.000305	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000181	0.000305	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ERCC2—urinary bladder cancer	0.000181	0.000623	CbGpPWpGaD
Isotretinoin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00018	0.000304	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—urinary bladder cancer	0.00018	0.000303	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000179	0.000302	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000179	0.000617	CbGpPWpGaD
Isotretinoin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000178	0.0003	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—urinary bladder cancer	0.000177	0.000299	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000177	0.000612	CbGpPWpGaD
Isotretinoin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000177	0.000298	CcSEcCtD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000177	0.000611	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000177	0.000611	CbGpPWpGaD
Isotretinoin—Dizziness—Fluorouracil—urinary bladder cancer	0.000177	0.000298	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—urinary bladder cancer	0.000176	0.000297	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000176	0.000297	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NCOR1—urinary bladder cancer	0.000176	0.000606	CbGpPWpGaD
Isotretinoin—Chills—Methotrexate—urinary bladder cancer	0.000175	0.000296	CcSEcCtD
Isotretinoin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000173	0.000292	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000173	0.000292	CcSEcCtD
Isotretinoin—Alopecia—Methotrexate—urinary bladder cancer	0.000173	0.000291	CcSEcCtD
Isotretinoin—Vomiting—Gemcitabine—urinary bladder cancer	0.000173	0.000291	CcSEcCtD
Isotretinoin—RARB—Gene Expression—NCOR1—urinary bladder cancer	0.000172	0.000595	CbGpPWpGaD
Isotretinoin—Mental disorder—Methotrexate—urinary bladder cancer	0.000171	0.000289	CcSEcCtD
Isotretinoin—Rash—Gemcitabine—urinary bladder cancer	0.000171	0.000289	CcSEcCtD
Isotretinoin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000171	0.000288	CcSEcCtD
Isotretinoin—Eye disorder—Epirubicin—urinary bladder cancer	0.000171	0.000288	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000171	0.000288	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—urinary bladder cancer	0.000171	0.000288	CcSEcCtD
Isotretinoin—Erythema—Methotrexate—urinary bladder cancer	0.00017	0.000287	CcSEcCtD
Isotretinoin—Malnutrition—Methotrexate—urinary bladder cancer	0.00017	0.000287	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00017	0.000287	CcSEcCtD
Isotretinoin—Headache—Gemcitabine—urinary bladder cancer	0.00017	0.000287	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—urinary bladder cancer	0.00017	0.000286	CcSEcCtD
Isotretinoin—Vomiting—Fluorouracil—urinary bladder cancer	0.00017	0.000286	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000169	0.000285	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000169	0.000285	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000169	0.000582	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000168	0.000284	CcSEcCtD
Isotretinoin—Rash—Fluorouracil—urinary bladder cancer	0.000168	0.000284	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—NCOR1—urinary bladder cancer	0.000168	0.000581	CbGpPWpGaD
Isotretinoin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000168	0.000284	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000168	0.000283	CcSEcCtD
Isotretinoin—Headache—Fluorouracil—urinary bladder cancer	0.000167	0.000282	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000282	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000167	0.000281	CcSEcCtD
Isotretinoin—Asthenia—Etoposide—urinary bladder cancer	0.000166	0.000281	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—urinary bladder cancer	0.000166	0.00028	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000166	0.00028	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NCOR1—urinary bladder cancer	0.000165	0.00057	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NCOR1—urinary bladder cancer	0.000165	0.00057	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ERCC2—urinary bladder cancer	0.000165	0.00057	CbGpPWpGaD
Isotretinoin—Back pain—Methotrexate—urinary bladder cancer	0.000165	0.000278	CcSEcCtD
Isotretinoin—Chills—Epirubicin—urinary bladder cancer	0.000164	0.000277	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000164	0.000566	CbGpPWpGaD
Isotretinoin—Pruritus—Etoposide—urinary bladder cancer	0.000164	0.000277	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000163	0.000276	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000163	0.000275	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000163	0.000563	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ERCC2—urinary bladder cancer	0.000162	0.000559	CbGpPWpGaD
Isotretinoin—Alopecia—Epirubicin—urinary bladder cancer	0.000162	0.000273	CcSEcCtD
Isotretinoin—Nausea—Gemcitabine—urinary bladder cancer	0.000161	0.000272	CcSEcCtD
Isotretinoin—Vomiting—Cisplatin—urinary bladder cancer	0.000161	0.000271	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—urinary bladder cancer	0.00016	0.00027	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—urinary bladder cancer	0.00016	0.00027	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00016	0.00027	CcSEcCtD
Isotretinoin—Rash—Cisplatin—urinary bladder cancer	0.00016	0.000269	CcSEcCtD
Isotretinoin—Dermatitis—Cisplatin—urinary bladder cancer	0.000159	0.000269	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—urinary bladder cancer	0.000159	0.000269	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—urinary bladder cancer	0.000159	0.000269	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—urinary bladder cancer	0.000159	0.000268	CcSEcCtD
Isotretinoin—Nausea—Fluorouracil—urinary bladder cancer	0.000159	0.000267	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000158	0.000267	CcSEcCtD
Isotretinoin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000158	0.000266	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000158	0.000266	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—urinary bladder cancer	0.000157	0.000265	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—urinary bladder cancer	0.000157	0.000265	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—urinary bladder cancer	0.000157	0.000265	CcSEcCtD
Isotretinoin—Tension—Epirubicin—urinary bladder cancer	0.000156	0.000264	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ERCC2—urinary bladder cancer	0.000155	0.000536	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ERCC2—urinary bladder cancer	0.000155	0.000536	CbGpPWpGaD
Isotretinoin—Nervousness—Epirubicin—urinary bladder cancer	0.000155	0.000261	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—urinary bladder cancer	0.000154	0.00026	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000154	0.000259	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—urinary bladder cancer	0.000153	0.000259	CcSEcCtD
Isotretinoin—Dizziness—Etoposide—urinary bladder cancer	0.000153	0.000259	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—urinary bladder cancer	0.000152	0.000256	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000151	0.000255	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR1—urinary bladder cancer	0.000151	0.000521	CbGpPWpGaD
Isotretinoin—Nausea—Cisplatin—urinary bladder cancer	0.00015	0.000253	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00015	0.000519	CbGpPWpGaD
Isotretinoin—Vision blurred—Epirubicin—urinary bladder cancer	0.00015	0.000253	CcSEcCtD
Isotretinoin—RXRA—Metabolism—TYMP—urinary bladder cancer	0.00015	0.000517	CbGpPWpGaD
Isotretinoin—Alopecia—Doxorubicin—urinary bladder cancer	0.00015	0.000252	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000149	0.000515	CbGpPWpGaD
Isotretinoin—Cough—Methotrexate—urinary bladder cancer	0.000149	0.00025	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000148	0.00025	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000148	0.000249	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—urinary bladder cancer	0.000147	0.000249	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—urinary bladder cancer	0.000147	0.000249	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—urinary bladder cancer	0.000147	0.000248	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000147	0.000248	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—urinary bladder cancer	0.000147	0.000248	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000147	0.000508	CbGpPWpGaD
Isotretinoin—Agitation—Epirubicin—urinary bladder cancer	0.000146	0.000247	CcSEcCtD
Isotretinoin—Rash—Etoposide—urinary bladder cancer	0.000146	0.000247	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000146	0.000505	CbGpPWpGaD
Isotretinoin—Dermatitis—Etoposide—urinary bladder cancer	0.000146	0.000246	CcSEcCtD
Isotretinoin—Headache—Etoposide—urinary bladder cancer	0.000145	0.000245	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—urinary bladder cancer	0.000145	0.000245	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—urinary bladder cancer	0.000145	0.000244	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—urinary bladder cancer	0.000145	0.000244	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—urinary bladder cancer	0.000145	0.000244	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—urinary bladder cancer	0.000145	0.000244	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000144	0.000497	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000144	0.000243	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000144	0.000496	CbGpPWpGaD
Isotretinoin—Malaise—Epirubicin—urinary bladder cancer	0.000144	0.000242	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—urinary bladder cancer	0.000143	0.000241	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—urinary bladder cancer	0.000143	0.000241	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—urinary bladder cancer	0.000143	0.000241	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—urinary bladder cancer	0.000143	0.00024	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—urinary bladder cancer	0.000141	0.000237	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00014	0.000485	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00014	0.000484	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00014	0.000484	CbGpPWpGaD
Isotretinoin—Confusional state—Methotrexate—urinary bladder cancer	0.00014	0.000236	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00014	0.000236	CcSEcCtD
Isotretinoin—Cough—Epirubicin—urinary bladder cancer	0.000139	0.000234	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000139	0.000234	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000139	0.000234	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—urinary bladder cancer	0.000138	0.000233	CcSEcCtD
Isotretinoin—Infection—Methotrexate—urinary bladder cancer	0.000138	0.000233	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR1—urinary bladder cancer	0.000138	0.000476	CbGpPWpGaD
Isotretinoin—Nausea—Etoposide—urinary bladder cancer	0.000138	0.000232	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPARG—urinary bladder cancer	0.000138	0.000475	CbGpPWpGaD
Isotretinoin—Hypertension—Epirubicin—urinary bladder cancer	0.000138	0.000232	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000137	0.000473	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000137	0.000231	CcSEcCtD
Isotretinoin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000136	0.00023	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—urinary bladder cancer	0.000136	0.00023	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000136	0.000229	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000136	0.000469	CbGpPWpGaD
Isotretinoin—Myalgia—Epirubicin—urinary bladder cancer	0.000136	0.000229	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—urinary bladder cancer	0.000136	0.000229	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—urinary bladder cancer	0.000136	0.000229	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NAT2—urinary bladder cancer	0.000136	0.000468	CbGpPWpGaD
Isotretinoin—Agitation—Doxorubicin—urinary bladder cancer	0.000135	0.000228	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ESR1—urinary bladder cancer	0.000135	0.000467	CbGpPWpGaD
Isotretinoin—Anxiety—Epirubicin—urinary bladder cancer	0.000135	0.000228	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—urinary bladder cancer	0.000135	0.000227	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000135	0.000227	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000134	0.000226	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—urinary bladder cancer	0.000134	0.000226	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—urinary bladder cancer	0.000133	0.000224	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CDK4—urinary bladder cancer	0.000133	0.000458	CbGpPWpGaD
Isotretinoin—Dry mouth—Epirubicin—urinary bladder cancer	0.000133	0.000224	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—urinary bladder cancer	0.000132	0.000223	CcSEcCtD
Isotretinoin—RARG—Gene Expression—CREBBP—urinary bladder cancer	0.000132	0.000456	CbGpPWpGaD
Isotretinoin—Syncope—Doxorubicin—urinary bladder cancer	0.000132	0.000223	CcSEcCtD
Isotretinoin—Confusional state—Epirubicin—urinary bladder cancer	0.000131	0.000221	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—urinary bladder cancer	0.00013	0.00022	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00013	0.000219	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—urinary bladder cancer	0.00013	0.000219	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—urinary bladder cancer	0.00013	0.000219	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—ESR1—urinary bladder cancer	0.00013	0.000448	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR1—urinary bladder cancer	0.00013	0.000448	CbGpPWpGaD
Isotretinoin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00013	0.000218	CcSEcCtD
Isotretinoin—Infection—Epirubicin—urinary bladder cancer	0.000129	0.000218	CcSEcCtD
Isotretinoin—Cough—Doxorubicin—urinary bladder cancer	0.000129	0.000217	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000128	0.000442	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMC1A—urinary bladder cancer	0.000128	0.000442	CbGpPWpGaD
Isotretinoin—Shock—Epirubicin—urinary bladder cancer	0.000128	0.000216	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—urinary bladder cancer	0.000128	0.000215	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000127	0.000215	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000127	0.000215	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—urinary bladder cancer	0.000127	0.000215	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—urinary bladder cancer	0.000127	0.000214	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000127	0.000213	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—urinary bladder cancer	0.000126	0.000213	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—PPARG—urinary bladder cancer	0.000126	0.000435	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000126	0.000212	CcSEcCtD
Isotretinoin—Insomnia—Methotrexate—urinary bladder cancer	0.000126	0.000212	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—urinary bladder cancer	0.000125	0.000212	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—urinary bladder cancer	0.000125	0.000212	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000125	0.000212	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—urinary bladder cancer	0.000125	0.000211	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000125	0.00021	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000125	0.00021	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—urinary bladder cancer	0.000124	0.000209	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—urinary bladder cancer	0.000124	0.000209	CcSEcCtD
Isotretinoin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000124	0.000209	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—urinary bladder cancer	0.000123	0.000208	CcSEcCtD
Isotretinoin—RARB—Gene Expression—PPARG—urinary bladder cancer	0.000123	0.000426	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000123	0.000425	CbGpPWpGaD
Isotretinoin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000123	0.000207	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000122	0.000206	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—urinary bladder cancer	0.000121	0.000205	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—urinary bladder cancer	0.000121	0.000204	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CREBBP—urinary bladder cancer	0.000121	0.000417	CbGpPWpGaD
Isotretinoin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000121	0.000204	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000121	0.000417	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PPARG—urinary bladder cancer	0.000121	0.000416	CbGpPWpGaD
Isotretinoin—Oedema—Doxorubicin—urinary bladder cancer	0.00012	0.000203	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00012	0.000203	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00012	0.000202	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—urinary bladder cancer	0.00012	0.000202	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—urinary bladder cancer	0.000119	0.000201	CcSEcCtD
Isotretinoin—Pain—Methotrexate—urinary bladder cancer	0.000119	0.0002	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CREBBP—urinary bladder cancer	0.000119	0.000409	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000118	0.0002	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—PPARG—urinary bladder cancer	0.000118	0.000409	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPARG—urinary bladder cancer	0.000118	0.000409	CbGpPWpGaD
Isotretinoin—Shock—Doxorubicin—urinary bladder cancer	0.000118	0.0002	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000118	0.000199	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000118	0.000199	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—urinary bladder cancer	0.000118	0.000198	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000117	0.000198	CcSEcCtD
Isotretinoin—RXRA—Metabolism—RRM2—urinary bladder cancer	0.000117	0.000404	CbGpPWpGaD
Isotretinoin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000117	0.000197	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000117	0.000197	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000116	0.000196	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000116	0.000195	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CREBBP—urinary bladder cancer	0.000116	0.0004	CbGpPWpGaD
Isotretinoin—Somnolence—Epirubicin—urinary bladder cancer	0.000116	0.000195	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—urinary bladder cancer	0.000115	0.000193	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000114	0.000193	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000114	0.000193	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—CREBBP—urinary bladder cancer	0.000114	0.000392	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CREBBP—urinary bladder cancer	0.000114	0.000392	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000114	0.000191	CcSEcCtD
Isotretinoin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000113	0.000191	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—urinary bladder cancer	0.000112	0.000189	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000112	0.000189	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—urinary bladder cancer	0.000112	0.000189	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—ESR2—urinary bladder cancer	0.000111	0.000385	CbGpPWpGaD
Isotretinoin—Constipation—Epirubicin—urinary bladder cancer	0.000111	0.000187	CcSEcCtD
Isotretinoin—Pain—Epirubicin—urinary bladder cancer	0.000111	0.000187	CcSEcCtD
Isotretinoin—Urticaria—Methotrexate—urinary bladder cancer	0.00011	0.000186	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00011	0.000185	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—urinary bladder cancer	0.00011	0.000185	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00011	0.000185	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—urinary bladder cancer	0.000109	0.000183	CcSEcCtD
Isotretinoin—RXRA—Metabolism—HPGDS—urinary bladder cancer	0.000108	0.000374	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO2—urinary bladder cancer	0.000108	0.000374	CbGpPWpGaD
Isotretinoin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000108	0.000182	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000108	0.000372	CbGpPWpGaD
Isotretinoin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000107	0.000181	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000107	0.000181	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—urinary bladder cancer	0.000107	0.00018	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000106	0.000179	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000106	0.000179	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTT1—urinary bladder cancer	0.000105	0.000363	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RHOA—urinary bladder cancer	0.000105	0.000362	CbGpPWpGaD
Isotretinoin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000105	0.000176	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000104	0.000175	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—urinary bladder cancer	0.000104	0.000175	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000103	0.000357	CbGpPWpGaD
Isotretinoin—Urticaria—Epirubicin—urinary bladder cancer	0.000103	0.000174	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—urinary bladder cancer	0.000103	0.000173	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—urinary bladder cancer	0.000103	0.000173	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000103	0.000173	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000103	0.000173	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000102	0.000173	CcSEcCtD
Isotretinoin—Asthenia—Methotrexate—urinary bladder cancer	9.97e-05	0.000168	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.91e-05	0.000167	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.84e-05	0.00034	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.84e-05	0.000166	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—urinary bladder cancer	9.83e-05	0.000166	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ERBB2—urinary bladder cancer	9.7e-05	0.000335	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—urinary bladder cancer	9.58e-05	0.000161	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—urinary bladder cancer	9.56e-05	0.000161	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—urinary bladder cancer	9.51e-05	0.00016	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.51e-05	0.00016	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—urinary bladder cancer	9.5e-05	0.00016	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—urinary bladder cancer	9.33e-05	0.000157	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—urinary bladder cancer	9.2e-05	0.000155	CcSEcCtD
Isotretinoin—Dizziness—Methotrexate—urinary bladder cancer	9.19e-05	0.000155	CcSEcCtD
Isotretinoin—Diarrhoea—Epirubicin—urinary bladder cancer	8.89e-05	0.00015	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.86e-05	0.000149	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—urinary bladder cancer	8.83e-05	0.000149	CcSEcCtD
Isotretinoin—Rash—Methotrexate—urinary bladder cancer	8.76e-05	0.000148	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—urinary bladder cancer	8.75e-05	0.000148	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NQO1—urinary bladder cancer	8.73e-05	0.000301	CbGpPWpGaD
Isotretinoin—Headache—Methotrexate—urinary bladder cancer	8.7e-05	0.000147	CcSEcCtD
Isotretinoin—Asthenia—Doxorubicin—urinary bladder cancer	8.63e-05	0.000145	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NCOR1—urinary bladder cancer	8.61e-05	0.000297	CbGpPWpGaD
Isotretinoin—Dizziness—Epirubicin—urinary bladder cancer	8.6e-05	0.000145	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—urinary bladder cancer	8.51e-05	0.000143	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.47e-05	0.000292	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—urinary bladder cancer	8.32e-05	0.000287	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—urinary bladder cancer	8.27e-05	0.000139	CcSEcCtD
Isotretinoin—Nausea—Methotrexate—urinary bladder cancer	8.25e-05	0.000139	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.23e-05	0.000139	CcSEcCtD
Isotretinoin—Rash—Epirubicin—urinary bladder cancer	8.2e-05	0.000138	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—urinary bladder cancer	8.19e-05	0.000138	CcSEcCtD
Isotretinoin—Headache—Epirubicin—urinary bladder cancer	8.14e-05	0.000137	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—ERCC2—urinary bladder cancer	8.09e-05	0.000279	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—urinary bladder cancer	7.95e-05	0.000134	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—EP300—urinary bladder cancer	7.89e-05	0.000272	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—urinary bladder cancer	7.85e-05	0.000271	CbGpPWpGaD
Isotretinoin—Nausea—Epirubicin—urinary bladder cancer	7.72e-05	0.00013	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SRC—urinary bladder cancer	7.67e-05	0.000265	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—urinary bladder cancer	7.65e-05	0.000129	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—urinary bladder cancer	7.58e-05	0.000128	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—urinary bladder cancer	7.58e-05	0.000128	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—urinary bladder cancer	7.54e-05	0.000127	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.39e-05	0.000255	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—urinary bladder cancer	7.3e-05	0.000252	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—urinary bladder cancer	7.28e-05	0.000251	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—urinary bladder cancer	7.18e-05	0.000248	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—urinary bladder cancer	7.14e-05	0.00012	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.05e-05	0.000243	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—urinary bladder cancer	7.04e-05	0.000243	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—urinary bladder cancer	6.77e-05	0.000234	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—urinary bladder cancer	6.76e-05	0.000233	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—urinary bladder cancer	6.75e-05	0.000233	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—urinary bladder cancer	6.75e-05	0.000233	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—urinary bladder cancer	6.72e-05	0.000232	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOR1—urinary bladder cancer	6.69e-05	0.000231	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—urinary bladder cancer	6.69e-05	0.000231	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX1—urinary bladder cancer	6.41e-05	0.000221	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—urinary bladder cancer	6.4e-05	0.000221	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—urinary bladder cancer	6.35e-05	0.000219	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ERCC2—urinary bladder cancer	6.29e-05	0.000217	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARG—urinary bladder cancer	6.17e-05	0.000213	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CREBBP—urinary bladder cancer	5.93e-05	0.000205	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—urinary bladder cancer	5.91e-05	0.000204	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—urinary bladder cancer	5.4e-05	0.000186	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARG—urinary bladder cancer	4.8e-05	0.000166	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CREBBP—urinary bladder cancer	4.61e-05	0.000159	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—urinary bladder cancer	3.77e-05	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—urinary bladder cancer	3.52e-05	0.000121	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—urinary bladder cancer	3.29e-05	0.000114	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—urinary bladder cancer	3.14e-05	0.000108	CbGpPWpGaD
